MX2007014963A - Composicion de liberacion modificada de al menos una forma de venlafaxina. - Google Patents

Composicion de liberacion modificada de al menos una forma de venlafaxina.

Info

Publication number
MX2007014963A
MX2007014963A MX2007014963A MX2007014963A MX2007014963A MX 2007014963 A MX2007014963 A MX 2007014963A MX 2007014963 A MX2007014963 A MX 2007014963A MX 2007014963 A MX2007014963 A MX 2007014963A MX 2007014963 A MX2007014963 A MX 2007014963A
Authority
MX
Mexico
Prior art keywords
venlafaxine
modified
release composition
pharmaceutically acceptable
composition
Prior art date
Application number
MX2007014963A
Other languages
English (en)
Inventor
Paul Maes
Werner Oberegger
Fang Zhou
Original Assignee
Biovail Lab Int Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovail Lab Int Srl filed Critical Biovail Lab Int Srl
Publication of MX2007014963A publication Critical patent/MX2007014963A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a una composicion de liberacion modificada de al menos una forma de venlafaxina, que es una composicion de liberacion controlada retardada. La composicion comprende un nucleo que contiene al menos una forma de venlafaxina seleccionada del grupo que consiste en venlafaxina, un metabolito activo de venlafaxina, una sal farmaceuticamente aceptable de venlafaxina, una sal farmaceuticamente aceptable de un metabolito activo de venlafaxina y sus combinaciones, menos de 10% de un gelificante y un excipiente farmaceuticamente aceptable. La composicion comprende ademas un recubrimiento de liberacion modificada que practicamente rodea el nucleo que proporciona una liberacion controlada retardada de la al menos una forma de venlafaxina.
MX2007014963A 2005-06-02 2006-06-02 Composicion de liberacion modificada de al menos una forma de venlafaxina. MX2007014963A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68646105P 2005-06-02 2005-06-02
US69128205P 2005-06-17 2005-06-17
PCT/US2006/021519 WO2006130843A1 (en) 2005-06-02 2006-06-02 Modified-release composition of at least one form of venlafaxine

Publications (1)

Publication Number Publication Date
MX2007014963A true MX2007014963A (es) 2008-04-17

Family

ID=37492005

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007014963A MX2007014963A (es) 2005-06-02 2006-06-02 Composicion de liberacion modificada de al menos una forma de venlafaxina.

Country Status (11)

Country Link
US (2) US20070098797A1 (es)
EP (1) EP1885340A1 (es)
JP (1) JP2008542394A (es)
KR (1) KR20080013927A (es)
AU (1) AU2006252394A1 (es)
CR (1) CR9555A (es)
IL (1) IL186756A0 (es)
MX (1) MX2007014963A (es)
NI (1) NI200700299A (es)
RU (1) RU2007143087A (es)
WO (1) WO2006130843A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080175873A1 (en) * 2005-06-02 2008-07-24 Biovail Laboratories International S.R.L. Modified release composition of at least one form of venlafaxine
US20070098797A1 (en) * 2005-06-02 2007-05-03 Biovail Laboratories International S.R.L. Modified release composition of at least one form of venlafaxine
WO2007112574A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Extended release composition of venlafaxine
KR100965527B1 (ko) * 2008-05-08 2010-06-23 제일약품주식회사 신규(4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시)포스페이트 또는 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계질환 예방 및 치료용 조성물
EP2296634A1 (en) * 2008-06-02 2011-03-23 Dexcel Pharma Technologies Ltd. Process for manufacture of a medicament with granulation and pan coating
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
EP2668945A1 (de) * 2012-06-01 2013-12-04 Bayer Technology Services GmbH Genotyp- bzw. Phänotyp-basierte Arzeimittelformulierungen
CN102772390B (zh) * 2012-08-16 2014-01-08 乐普药业股份有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US432607A (en) * 1890-07-22 dwyer
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
US20050244498A1 (en) * 2001-09-14 2005-11-03 Biovail Laboratories, Inc. Modified-release compositions of at least one form of venlafaxine
CA2470636A1 (en) * 2001-12-20 2003-07-03 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
AR039163A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Besilato de venlafaxina
US20080175873A1 (en) * 2005-06-02 2008-07-24 Biovail Laboratories International S.R.L. Modified release composition of at least one form of venlafaxine
US20070098797A1 (en) * 2005-06-02 2007-05-03 Biovail Laboratories International S.R.L. Modified release composition of at least one form of venlafaxine

Also Published As

Publication number Publication date
RU2007143087A (ru) 2009-07-20
EP1885340A1 (en) 2008-02-13
KR20080013927A (ko) 2008-02-13
IL186756A0 (en) 2008-02-09
NI200700299A (es) 2008-07-24
US20090269402A1 (en) 2009-10-29
AU2006252394A1 (en) 2006-12-07
JP2008542394A (ja) 2008-11-27
WO2006130843A1 (en) 2006-12-07
CR9555A (es) 2008-06-12
US20070098797A1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
MX2007014963A (es) Composicion de liberacion modificada de al menos una forma de venlafaxina.
WO2007090882A3 (en) Pharmaceutical extended release compositions comprising pramipexole
MY127797A (en) 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol-containing pharmaceutical composition with slow release of active indgredient
PT1465608E (pt) Composições de libertação prolongada compreendendo como composto activo hidrocloreto de venlafaxina
MY148844A (en) Fumarate salt of (alpha s, beta r)-6- bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
WO2007117465A3 (en) Indazole compounds
MX2007013623A (es) Preparacion externa para la piel.
HK1133596A1 (en) Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
HK1098364A1 (en) Pellets containing venlafaxine hydrochloride
MX2010007672A (es) Composicion estabilizada de liberacion sostenida de clorhidrato de bupropion y proceso para su preparacion.
BRPI0709057C1 (pt) veículo mucoso bioadesivo de lenta liberação, método para preparar um veículo mucoso bioadesivo de lenta liberação, e, uso do veículo mucoso bioadesivo de lenta liberação
HK1125291A1 (en) Method of using guava extract and composition including guava extract
UA90130C2 (ru) Аморфный лерканидипина гидрохлорид и фармацевтическая композиция на его основе
UA87515C2 (ru) Фармацевтическая композиция толтеродина с пролонгированным высвобождением
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
TW200727892A (en) Formulations of suberoylanilide hydroxamic acid and methods for producing same
UA105022C2 (uk) Композиція для боротьби з хворобами рослин та спосіб боротьби з хворобами рослин
WO2007123883A3 (en) Oral dosage formulations and methods of preparing the same
EP1944027A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF NEPHRITIS AND METHOD FOR PRODUCING THE SAME
TW200724145A (en) Substituted acrylamide derivatives and pharmaceutical compositions thereof
TW200740428A (en) Substituted propanamide derivatives and pharmaceutical compositions thereof
TW200706173A (en) Oral composition comprising carbamylating agent
WO2008022745A8 (de) Formulierungen zur kontrollierten freisetzung agrochemischer wirkstoffe
HUP0301537A2 (hu) Deramcyclane-fumarátot tartalmazó tabletták és eljárás előállításukra